Deep Brain Stimulation In Parkinson’s Disease Market To Reach $1.61 Billion By 2030

Deep Brain Stimulation In Parkinson’s Disease Market Growth & Trends

The global deep brain stimulation in Parkinson’s disease market size is anticipated to reach USD 1.61 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.1% from 2025 to 2030. Surge in the incidence of Parkinson’s Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson’s disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson’s disease, which is expected to fuel the market growth during the forecast period.

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott’s Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

 Request a free sample copy or view report summary: Deep Brain Stimulation In Parkinson’s Disease Market Report

Deep Brain Stimulation In Parkinson’s Disease Market Report Highlights

• The dual channel segment dominated the market with the share of 56.9% in 2024 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors

• On the basis of end-use, hospitals dominated the market in 2024 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment

• North America dominated the market with in 2024 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.

Deep Brain Stimulation In Parkinson’s Disease Market Segmentation

Grand View Research has segmented the global DBS in Parkinson’s disease market on the basis of product, end-use, and region:

Deep Brain Stimulation In Parkinson’s Disease Product Outlook (Revenue, USD Million, 2018 - 2030)

• Single-channel

• Dual-channel

Deep Brain Stimulation In Parkinson’s Disease End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Neurology Clinics

• Ambulatory Surgical Centers

• Research Centers

Deep Brain Stimulation In Parkinson’s Disease Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Indonesia

  • South Korea

  • Thailand

  • Australia

  • Philippines

  • Malaysia

  • Singapore

• Latin America

  • Brazil

  • Argentina

  • Colombia

  • Chile

  • Venezuela

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • United Arab Emirates

  • Turkey

  • Iran

  • Kuwait

List of Key Players in the Deep Brain Stimulation In Parkinson’s Disease Market

• ABBOTT

• Medtronic

• Boston Scientific Corporation